ABSTRACT
Parasitic diseases caused by gastrointestinal nematodes (GIN) are responsible for a major impact on ruminant welfare. Although the available anthelmintics have a safe margin of toxicity to the animals, their indiscriminate use has increased the selection of resistant parasite populations. In this scenario, essential oils (EO) stand out as a promising ecofriendly therapeutic alternative against GIN. The objective of this work was to determine the effect of the EO of Mentha villosa Hubs (MVEO) collected in 2017 and 2018, M. x piperita (MPEO) and their main components, carvone and limonene, against the third stage larvae (L3) of Haemonchus spp. and Trichostrongylus spp. The solutions, including in nanoemulsion preparations, were tested in a range of concentrations using the larval migration inhibition test (LMIT). The EO and carvone were also tested in combination with nitroxynil (NTX) to determine their effect as drug enhancers (additive or synergy). MVEO/2017, MVEO/2018, MPEO and carvone showed 70.6 (73.4â¯mg/mL), 86.3 (74.9â¯mL/mL), 95.5 (143.6â¯mg/mL), and 88.2 % (38.3â¯mg/mL) efficacy against L3, respectively. Carvone alone had approximately a 3-fold higher efficacy when compared to its concentration in each EO: 68.8 % in MVEO/2017 and 83.9 % in MVEO/2018. Limonene did not show any significant effect on inhibiting L3 migration. The combination of MPEO and NTX, and carvone and NTX showed a statistically significantly (Pâ¯<⯠0.05) synergic and additive effect, respectively, when compared to the isolated treatment. The nanoemulsion of MVEO/2017 at 0.367 mg/mL, inhibited L3 migration by 83.1 %, demonstrating to be highly effective (concentration ratio of 1:0.004), when compared to the MVEO/2017 (70.6 % at 73.4 mg/mL) extraction. The in vitro data from the combination of MPEO or carvone plus NTX suggest that these products can be considered for in vivo experiments against the most important GIN of ruminants as drug enhancers, possibly reducing the final concentration of NTX`. The efficacy of carvone was higher (EC50â¯=â¯1.96â¯mg/mL) than its expected efficacy, based on its concentrations on both EO. Therefore, this component does not need the entire EO composition to exert its L3 motility action. The remarkable efficacy demonstrated by the MVEO/2017/nanoemulsion (EC50â¯=â¯0.10â¯mg/mL), supports its potential to be a candidate to the next-generation therapy to alleviate clinical parasite infections and combat GIN resistant populations.
Subject(s)
Anthelmintics/pharmacology , Mentha/chemistry , Nematoda/drug effects , Phytochemicals/pharmacology , Plant Oils/pharmacology , Animals , Anthelmintics/administration & dosage , Anthelmintics/chemistry , Cyclohexane Monoterpenes/administration & dosage , Cyclohexane Monoterpenes/chemistry , Cyclohexane Monoterpenes/pharmacology , Drug Synergism , Drug Therapy, Combination , Limonene/administration & dosage , Limonene/chemistry , Limonene/pharmacology , Nematode Infections/parasitology , Nematode Infections/veterinary , Nitroxinil/administration & dosage , Nitroxinil/chemistry , Nitroxinil/pharmacology , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Phytochemicals/chemistry , Plant Oils/chemistry , Sheep , Sheep Diseases/parasitologyABSTRACT
The aim of this study was to compare the efficacy of triclabendazole (TCBZ) and nitroxynil against a TCBZ-resistant Fasciola hepatica strain in a naturally infected sheep flock. The efficacies were measured by the faecal egg count reduction test. The level of F. hepatica antigens was tested in faeces; and haematological indices such as total proteins (TP), albumin, hepatic enzymes and total IgG were also studied. The results confirmed the resistance of F. hepatica against TCBZ in the flock with an efficacy during the first month post-treatment between 59.4% and 73.8%. In the nitroxynil group, the efficacy during the same period ranged between 81.3% and 86%, likely because the efficacy of this drug against 7- to 9-week-old immature stages is only 50-90%. Anemia was showed in all groups and white blood cells were always higher than the reference range. The values of TP and albumin were within normal range in most of the sheep, and an increase in hepatic enzymes confirmed the liver damage. Regarding total IgG, some negative correlations were found with egg excretion, and in relation to the level of antigens in faeces, these ones decreased immediately after treatment. We conclude that nitroxynil could be an alternative in case of TCBZ resistance.
Subject(s)
Anthelmintics/administration & dosage , Benzimidazoles/administration & dosage , Drug Resistance , Fasciola hepatica/drug effects , Fascioliasis/veterinary , Nitroxinil/administration & dosage , Sheep Diseases/drug therapy , Anemia/parasitology , Animals , Anthelmintics/pharmacology , Antibodies, Helminth/blood , Benzimidazoles/pharmacology , Blood Chemical Analysis , Fascioliasis/drug therapy , Fascioliasis/parasitology , Fascioliasis/pathology , Feces/parasitology , Immunoglobulin G/blood , Leukocyte Count , Nitroxinil/pharmacology , Parasite Egg Count , Sheep , Treatment Outcome , TriclabendazoleABSTRACT
The effect of age/body weight in the plasma disposition kinetics of ivermectin (IVM) and nitroxynil (NTX) after their co-administration as a combined formulation to sheep was studied. Sixteen (16) male sheep were allocated into two experimental groups (n=8 each): (a) high body weight (high bw) (18-20 months old), and (b) low body weight (low bw) (6-8 months old). Animals in both groups were subcutaneously (sc) treated with IVM (200 microg/kg) and NTX (10 mg/kg) using a commercially available combined formulation (Nitromectin, Lab. Ovejero, Spain). Blood samples were taken by jugular venopuncture before (time 0), at 2, 4, 8, 12 h and at 1, 2, 3, 5, 7, 10, 15, 20, 25, 35, 40, 50 and 60 days after administration. Recovered plasma was analysed to quantify IVM and NTX by HPLC. Higher IVM plasma concentrations were measured until 20 days post-administration in "low bw" compared to "high bw" animals, where IVM was recovered up to 35 days post-treatment. The IVM absorption process greatly differed between experimental groups. A significantly higher (p<0.01) C(max) (36.7+/-7.52 ng/ml) value was obtained at a delayed (p<0.05) T(max) (48.0+/-0.0 h) in light compared to heavy (C(max): 8.0+/-0.80 ng/ml; at 34.0 h) body weight sheep. IVM elimination half-life and mean residence time were significantly shorter in light compared to heavy (older) sheep. NTX mean plasma concentrations were lower in "low bw" compared to those measured in "high bw" sheep, with elimination phases declining up to 60 d post-administration in both experimental groups. The NTX AUC value in "low bw" (1188.5+/-122.6 microg day/ml) was significantly lower (p<0.05) than that obtained in the "high bw" (oldest) animals (1735.0+/-155.8 microg day/ml). Shorter NTX elimination half-life and mean residence time (p<0.01) were obtained in the youngest ("low bw") compared to the oldest (high bw) sheep. The work reported here assessed for the first time the disposition of IVM and NTX after their combinated injection to sheep, demonstrating that animal body weight/development greatly affects the kinetic behaviour of both anthelmintic drugs.
Subject(s)
Ivermectin/administration & dosage , Ivermectin/pharmacokinetics , Nitroxinil/administration & dosage , Nitroxinil/pharmacokinetics , Sheep/metabolism , Aging , Animals , Antiparasitic Agents/pharmacokinetics , Antiparasitic Agents/pharmacology , Area Under Curve , Body Weight , Drug Combinations , Half-Life , Injections, Subcutaneous , MaleABSTRACT
The objective was to compare the efficacy against artificially induced 2- and 4-week old early immature triclabendazole-susceptible liver flukes (Fasciola hepatica) of an injectable combination of nitroxynil, clorsulon and ivermectin with oral and pour-on combination formulations containing triclabendazole. Groups of yearling Angus or Angus cross cattle were confirmed fluke free before being artificially infected with 500 Sunny Corner strain triclabendazole-susceptible liver fluke metacercariae. Two or four weeks after infection, cattle were treated with the test combination Nitromec (10.2mg/kg nitroxynil, 2.0mg/kg clorsulon, 0.2mg/kg ivermectin), or oral Flukazole C+Se (triclabendazole/oxfendazole/Selenium), oral Fasimec C (triclabendazole/ivermectin) or Genesis Ultra Pour-On (triclabendazole/abamectin). At intervals cattle were weighed, faecal sampled for liver fluke egg counts and blood sampled for liver serum enzyme analysis. Cattle were slaughtered 14 weeks after infection for recovery of adult flukes; fluke egg counts and liver pathology assessment. All cattle increased in body weight by 0.4-0.8kg/day but there were no significant differences between control and treated groups or between the treatment groups. Geometric mean 14-week fluke egg counts and total fluke counts for all treatments, were significantly less (p<0.05) than the control group, except for the group treated with Genesis Ultra Pour-On, 2 weeks after infection. Nitromec treatment of 2-week old flukes was 83% and 95% effective as assessed by 14-week egg and fluke counts, respectively, compared to Flukazole C; 96% and 99%, Fasimec C; 70% and 46%, and Genesis Pour-On, which was ineffective, with egg and fluke count reductions of 0% and 8%, respectively. Against 4-week old flukes, Nitromec treatment was 88% and 99% effective when assessed by 14-week egg and fluke counts, respectively, with Flukazole C; 98% and 99%, Genesis Pour-On; 98% and 82% and Fasimec C; 91% and 61% effective, respectively. Group mean levels of the bile duct-associated enzyme gamma glutamyl transpeptidase (GGT) and the parenchymal associated enzymes, aspartate amino-transferase (AST) and glutamate dehydrogenase (GLDH) increased above the normal range 8 and 11 weeks after infection in the untreated control animals and the group treated 2 weeks after infection with Genesis Pour-On. The groups treated with Fasimec at 2 or 4 weeks after infection, also had elevated enzyme levels. The use of liver-associated enzyme assay is supported as supplementary indicators of fluke-induced pathology.
Subject(s)
Benzimidazoles/therapeutic use , Cattle Diseases/drug therapy , Fascioliasis/veterinary , Ivermectin/therapeutic use , Nitroxinil/therapeutic use , Sulfanilamides/therapeutic use , Administration, Oral , Administration, Topical , Animals , Anthelmintics/administration & dosage , Anthelmintics/therapeutic use , Benzimidazoles/administration & dosage , Cattle , Cattle Diseases/pathology , Drug Combinations , Fasciola hepatica , Fascioliasis/drug therapy , Fascioliasis/pathology , Ivermectin/administration & dosage , Ivermectin/analogs & derivatives , Male , Nitroxinil/administration & dosage , Parasite Egg Count , Sulfanilamides/administration & dosage , TriclabendazoleABSTRACT
Male Sprague-Dawley rats were dosed orally with nitroxynil at a concentration of 40 mg/kg, and adult Fasciola hepatica were recovered after 24, 48 and 72 h. Fine structural changes to the tegument and gut were monitored by transmission electron microscopy. Flukes were also incubated for 24 h in vitro in nitroxynil at a concentration of 100 microg/ml. Following treatment in vivo, there was an accumulation and accelerated release of secretory bodies at the apex of the tegumental syncytium. Some swelling of the mucopolysaccharide masses surrounding the basal infolds was evident after 48 and 72 h. There was an initial accumulation of T1 secretory bodies at the base of the syncytium, but this decreased at 72 h, coinciding with a decline in their production in the tegumental cells. The mitochondria were consistently swollen in the tegumental cells. At 72 h, large vacuolations were observed between the muscle layers and there was flooding around the underlying tissues. Some tegumental cells were seen to be degenerating and beginning to disintegrate. After 24 h treatment in vitro, the basal infolds were swollen and the crystalline structure of the spines was disrupted. Flooding of the internal tissues was evident and, in the tegumental cells, Golgi complexes and secretory bodies were absent. The mitochondria in the tegumental cells were swollen. In the gastrodermal cells, changes were evident at the earliest time period in vivo. The lamellae were disrupted, few secretory bodies were present, the mitochondria and cisternae of granular endoplasmic reticulum (ger) were swollen and there was an increased number of secretory bodies. These changes became progressively more severe with time. Similar changes were evident following treatment in vitro; vesiculation of the ger was also seen. The results indicate that oral uptake is the predominant route of entry of nitroxynil into the fluke.
Subject(s)
Antiplatyhelmintic Agents/pharmacology , Fasciola hepatica/drug effects , Fasciola hepatica/ultrastructure , Fascioliasis/drug therapy , Nitroxinil/pharmacology , Animals , Antiplatyhelmintic Agents/administration & dosage , Antiplatyhelmintic Agents/therapeutic use , Fascioliasis/parasitology , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/ultrastructure , Male , Microscopy, Electron, Transmission , Nitroxinil/administration & dosage , Nitroxinil/therapeutic use , Rats , Rats, Sprague-DawleyABSTRACT
In eight controlled tests 274 cattle were used to assess the efficacies of triclabendazole, albendazole, clorsulon, nitroxynil, oxyclozanide and rafoxanide against Fasciola hepatica. Against one-, two- and four-week-old early immature fluke the mean efficacies of triclabendazole given orally at 12 mg/kg were 88.1, 95.3 and 90.7 per cent, respectively. Clorsulon, nitroxynil and rafoxanide administered at recommended dose rates showed negligible activity against these stages of the parasite. Against six- and eight-week-old infections the mean efficacies of triclabendazole at 12 mg/kg were 87.5 per cent and 95.7 per cent, respectively. Against F hepatica aged six weeks, albendazole and oxyclozanide showed no activity and clorsulon, nitroxynil and rafoxanide had only slight to moderate activity. The efficacies of triclabendazole, clorsulon, nitroxynil and rafoxanide against 10- or 12-week-old parasites were 100, 99.0, 99.1 and 90.1 per cent, respectively. Albendazole and oxyclozanide showed poor efficacy against 12-week-old infections.
Subject(s)
Benzimidazoles/pharmacology , Cattle Diseases/drug therapy , Fascioliasis/veterinary , Administration, Oral , Albendazole/administration & dosage , Albendazole/pharmacology , Animals , Benzimidazoles/administration & dosage , Cattle , Drug Resistance , Fascioliasis/drug therapy , Female , Injections, Subcutaneous/veterinary , Male , Nitroxinil/administration & dosage , Nitroxinil/pharmacology , Oxyclozanide/administration & dosage , Oxyclozanide/pharmacology , Parasite Egg Count/veterinary , Rafoxanide/administration & dosage , Rafoxanide/pharmacology , Sulfanilamides/administration & dosage , Sulfanilamides/pharmacology , Time Factors , TriclabendazoleABSTRACT
The efficacy of nitroxynil administered once by subcutaneous injection at a dosage regimen of 20 mg/kg live mass was evaluated against natural infestations of parafilaria bovicola in cattle. Trial animals were slaughtered 14 weeks after treatment. Treatment reduced the number of bleeding points by 97,8%, eosinophil-positive carcass lesions by 85,7% and eosinophil-positive lesion area by 92,8%, compared with controls.
Subject(s)
Cattle Diseases/drug therapy , Filariasis/veterinary , Nitrophenols/administration & dosage , Nitroxinil/administration & dosage , Animals , Cattle , Filariasis/drug therapy , Injections, Subcutaneous , Male , Time FactorsABSTRACT
Nitroxynil distribution and the period of its retention in the organism of sheep and calves subcutaneously treated with therapeutical doses of the Bulgarian patent medicine fasciolid which contains N-methylglucaminic-nitro-xynil salt were followed. Comparative studies were carried out using the patent medicine dovenix "Specia". The polarographic method, based on nitro-group reduction over a dripping mercury electrod was applied for nitroxynil determination. It was established that fasciolid and dovenix applied to sheep and cattle in a prophylactic-therapeutic dose did not differ significantly in their distribution and retention in the organism.
Subject(s)
Cattle/metabolism , Nitrophenols/metabolism , Nitroxinil/metabolism , Sheep/metabolism , Animals , Nitroxinil/administration & dosage , Nitroxinil/analogs & derivatives , Solutions , Time Factors , Tissue DistributionABSTRACT
Nitroxynil injected subcutaneously at 10 mg/kg live mass achieved Class A efficacy when evaluated by the non parametric method against adult Fasciola gigantica. Haemonchus placei, Bonustomum phlebotomum and Oesophagostomum radiatum in cattle. The compound was not effective against adult Cooperia spp. at the same dosage.
Subject(s)
Cattle/parasitology , Nitrophenols , Nitroxinil , Ancylostomatoidea , Animals , Drug Evaluation/veterinary , Fasciola , Haemonchus , Injections, Subcutaneous , Nitrophenols/administration & dosage , Nitroxinil/administration & dosage , Oesophagostomum , TrichostrongyloideaABSTRACT
Diamphenethide and a mixture of nitroxynil and hexachlorophane, which are effective against Fasciola hepatica in sheep, are effective in cattle if allowance is made for the slower rate of development and the more intense liver reaction which is associated with resistance. Adult parasites are mostly rejected around the time of maturity so that therapy in cattle must be directed against the early developmental stage using an appropriate drug.